In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
COVID-19 and Cardiology Read more

A 55-year-old male asymptomatic endurance athlete with obstructive coronary disease: To stent or not to stent?

Sabiha Gati, Sports Cardiology Quiz Section Editor

Management of obstructive coronary artery disease with silent ischaemia in masters athletes.

Rehabilitation and Sports Cardiology


A 55-year-old male who is a competitive cyclist and runner presents for assessment after undergoing a screening exercise stress test (EST) done on the request of the patient following the recent sports-related sudden cardiac death (SrSCD) of a training partner.

His exercise stress test demonstrated:

  • A high fitness capacity (18.7 METS)
  • A normal resting electrocardiogram (Image 1) but was electrically positive with >1mm of downsloping ST-depression in the anterior leads (Image 2), in addition to demonstrating a hypertensive response to exercise

In addition:

  • He experiences no angina or anginal equivalents
  • He has no past medical history or significant family history, takes no regular medications
  • He is a lifelong non-smoker
  • He has a normal resting blood pressure.

Given his EST findings, baseline bloodwork is ordered to assess his cardiovascular risk profile and a coronary CT angiogram (CCTA) is arranged. His total cholesterol is 6.93mmol/L, his LDL is 4.4mmol/L, his HDL is 1.25mmol/L, and his HbA1c is 5.4%. His SCORE is 2%.

His CCTA demonstrates a 70% lesion in his proximal left circumflex artery and a densely calcified proximal and mid left anterior descending artery unable to be quantified due to the severity of calcification.

The management of asymptomatic masters athletes diagnosed with obstructive coronary artery disease (CAD) and demonstratable ischaemia remains a clinical dilemma. The European Association of Preventive Cardiology (EAPC) guidelines recommend revascularization if ischaemia is present, however the evidence underpinning this recommendation is limited. When obstructive CAD is discovered in middle-aged athletes who exercise at high-intensities (and frequently push their ischaemic thresholds), should more aggressive revascularization strategies truly be pursued in addition to optimal medical therapy (OMT) versus OMT alone or is revascularization an unnecessary added risk?

Image 1: Exercise Stress Test pre-PCI

2020-sports-cardiology-case11-image1.JPG

 

Image 2: Exercise Stress Test pre-PCI

2020-sports-cardiology-case11-image2.JPG

 

Test Your Knowledge

 

Case report

Read the corresponding case report: 

"Do athletes play by different rules? Obstructive coronary artery disease in asymptomatic competitive masters athletes: a case series

James McKinney MD et al.; European Heart Journal - Case Reports, 26 March 2020, ytaa016 

Interested in learning more? Access the ESC e-Learning Platform and discover the EAPC Sports Cardiology online courses. 

EAPC online educational courses are only accessible to EAPC Ivory, Silver and Gold Members. Not yet an EAPC Member? 

Join now

Note: The views and opinions expressed on this page are those of the author and may not be accepted by others. While every attempt is made to keep the information up to date, there is always going to be a lag in updating information. The reader is encouraged to read this in conjunction with appropriate ESC Guidelines. The material on this page is for educational purposes and is not for use as a definitive management strategy in the care of patients. Quiz material on the site are only examples and do not guarantee outcomes from formal examinations.

 

Notes to editor

Author information
James McKinney MD, MSca,b; Nathaniel Moulson MDa,b, Barbara N. Morrison MSca; Jobanjit S. Phulka BHSca; Phillip YeungBSca; Saul Isserow MB Ch.Ba,b; David A. Wood MDa,b
Author Affiliations:
SportsCardiologyBC, University of British Columbia, Vancouver, British Columbia, Canadaa
Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canadab